Messages
1/18/2024
13 : 34
European VC simmers down
More banks muscle in on private credit; 5 funds to watch in the secondary market; VCs face natural selection Read online | Don't want to receive these emails? Manage your subscription. Log in The
1/17/2024
12 : 44
VC's role in voluntary carbon markets
VC funds take longer and longer to close; investors on fintech startups to know; PE buyers target cash-constrained startups Read online | Don't want to receive these emails? Manage your
1/16/2024
12 : 54
VCs dream of more-human robots
Is a VC recovery on the horizon for Europe?; charting a leveraged loan repricing wave; where do PE deals go from here? Read online | Don't want to receive these emails? Manage your subscription.
1/15/2024
12 : 44
Takeaways for VC from healthcare event
Deal news dwindled at JP Morgan's healthcare conference; BlackRock makes $12.5B infrastructure bet; Fullcast's $34M seed funding Read online | Don't want to receive these emails? Manage
1/14/2024
11 : 24
VCs face natural selection
Plus: Positive VC outlook for AI, the whys behind PE's thirst for liquidity, valuation guides for public tech sectors & more Read online | Don't want to receive these emails? Manage your
1/13/2024
11 : 34
Why PE is set to rebound in 2024
Also: 17 key takeaways from the 2024 JP Morgan Healthcare Conference; Humanoid robots are coming; Our latest public comp sheets and valuation guides Read online | Don't want to receive these emails
1/12/2024
13 : 24
Our freshest fund performance data
Charting VC dealmaking's big pivot; sizing up public foodtech, agtech valuations; healthcare investors move with caution Read online | Don't want to receive these emails? Manage your
1/12/2024
9 : 24
VCs hold fire on continuation funds—for now
Enterprise SaaS copes with a leaner market; PE needs an exit reboot; Cinven bags 2024's first mega-fund Read online | Don't want to receive these emails? Manage your subscription. Log in The
1/12/2024
9 : 15
VC looks for sunnier skies
Female founders' strong finish to 2023; semiconductors ride a generative AI wave; auto commerce returns lead public mobility tech Read online | Don't want to receive these emails? Manage your
1/9/2024
11 : 54
Coinbase leads VC's crypto retreat
Obesity drug market's future in focus; mobility tech's fossil-free revolution; mapping France's muted VC ecosystem; Thrive Capital targets $3B fund Read online | Don't want to receive
1/8/2024
12 : 44
3 VC sectors feel extra pressure for returns
Carbon recycling offers sustainable investments; Vico Therapeutics secures $60M Series B; TCG Crossover wraps up $1B second fund Read online | Don't want to receive these emails? Manage your
1/7/2024
11 : 34
PE needs to get creative in 2024
Plus: A first look at the PitchBook-NVCA Venture Monitor, semiconductors lose luster with VC, a liquidity crunch & more Read online | Don't want to receive these emails? Manage your
1/6/2024
11 : 44
A first look at 2023 VC data
Also: December performance across the global markets; Diving into VC-backed IPO opportunities by vertical; Tech research on semiconductor scale-ups... Read online | Don't want to receive these
1/5/2024
12 : 54
Gen AI services startups find a niche
December's equity, debt and commodities trends; ranking European VC's top investors; OnCusp Therapeutics rakes in $100M Read online | Don't want to receive these emails? Manage your
1/4/2024
12 : 34
A preview of VC's final 2023 data
Preliminary PE data charts the decline; crypto VC weighs similarities to generative AI craze; PE is optimistic for exit rebound Read online | Don't want to receive these emails? Manage your
1/3/2024
12 : 54
Semiconductors losing luster with VC
5 startups on track for unicorn status; fundraising predictions for 2024; Apollo Therapeutics extends Series C to $260M Read online | Don't want to receive these emails? Manage your subscription.
1/2/2024
11 : 24
Some VCs hold fire on hydrogen
Drilling down on impact investing performance; a full secondaries pipeline; Europe's year of the mega-fund Read online | Don't want to receive these emails? Manage your subscription. Log in The
1/1/2024
11 : 24
Our 2024 outlooks
Analyst predictions across US venture capital, private equity, healthcare, emerging technologies, the LP perspective, and European private capital... Read online | Don't want to receive these
12/31/2023
12 : 4
Exit hangover: 2024's fundraising dilemma
Plus: Our analysts offer outlooks for PE and VC in 2024, latest Emerging Tech Research highlights the hotspots & more Read online | Don't want to receive these emails? Manage your subscription.
12/30/2023
11 : 44
Our best research of 2023
Recapping 17 of our analyst picks from the past year, including our global VC ecosystem rankings and whether or not ESG investors are underperforming. Read online | Don't want to receive these